SYDNEY--15 Jan--AsiaNet/InfoQuest
NEW BRIBELINE...
NEW DELHI: TRACE International, Inc. today announced results from its first
16 months of collecting and analyzing reports of bribery demands in India.
These reports represent the first look at the demand-side of bribery in India
as reported directly by those being solicited for bribes.
www.TRACEinternational.org
EXCLUSIVE TRADEMARK...
SINGAPORE: Telnic Limited, the registry operator for the new .tel top level
domain (TLD) already described by Fortune/CNN as "The Google of online phone
books" today reminded businesses with trademarks that there were only fifteen
working days left to protect their .tel domains in the Sunrise period.
http://www.telnic.org .
NEW BD BACTEC...
SPARKS: BD Diagnostics, a segment of BD, today announced the worldwide
launch of the BD BACTEC(TM) FX Blood Culture System to detect bloodstream
infections. This new system improves clinical decision-making and laboratory
workflow by markedly improving blood culturing practices with real-time,
remotely accessible, actionable results that can enhance patient care.
www.bd.com
GERMANISCHER LLOYD...
SINGAPORE and HAMBURG: Airborne Systems, a world leader in parachute design
and manufacturing, announced they successfully completed a test drop deploying
an 18,000 lb payload from 17,500 MSL under a modified modular ram-air parachute.
www.airborne-sys.com
DUBAI CUSTOMS...
DUBAI: Mr. Abdul Rahman Al Saleh, the senior Executive Director of Corporate
Affairs at Dubai Customs has revealed that he foiled a number of attempts last
year to smuggle banned rare animals into the country.
FANNIE MAE...
WASHINGTON, D.C.: Fannie Mae will redeem the principal amount of xxx
securities issues amounting to a total of US$450 million on October 24, 2012,
April 24, 2013 at a redemption price equal to 100 per cent of the principal
amount redeemed plus accrued interest.
http://www.fanniemae.com
ACLI PRAISES...
WASHINGTON: The American Council of Life Insurers (ACLI) congratulated the
U.S. and Japanese governments for achievements under the U.S.-Japan Economic
Partnership for Growth, including the Regulatory Reform and Competition Policy
Initiative ("Regulatory Reform Initiative").
www.acli.com
EURAIL WILL...
UTRECHT: A new year is upon us and, as ever, many organizations and
publications are coming out with their lists of top destinations to visit for
2009.
http://eurail.informationstore.net
KENDLE EXPANDS...
CINCINNATI: Kendle (Nasdaq: KNDL), a leading, global full-service clinical
research organization, today announced the opening of a second office in
western India in the city of Ahmedabad, further expanding its presence in the
country and executing on its plans for continued growth in the Asia/Pacific
region.
www.kendle.com
NORONT CONTINUES...
TORONTO: Noront Resources Ltd. ("Noront or the Company") (TSX Venture: NOT)
is pleased to present additional chromium assay results from its chromite
exploration activities in the McFaulds Lake area of northern Ontario in the
James Bay Lowlands.
http://www.norontresources.com
U.S. COURT...
BOCA RATON: ADT Security Services, the leading provider of Sensormatic
Electronic Article Surveillance (EAS) solutions, today announced a victory in a
major lawsuit against a competing company that was found liable for patent
infringement, misappropriating trade secrets and employing unfair trade
practices.
www.adt.com/global
SENIORS IN JAPAN...
TOKYO: Yahoo! Mail Ranks as Top Web-Based Email Service in Japan
comScore, Inc. (Nasdaq: SCOR), a leader in measuring the digital world,
today released a study of Web-based email usage in Japan, which showed that the
number of visitors to email sites increased 22 percent during the past year,
fueled in large part by greater adoption among older Internet users.
http://www.comscore.com/companyinfo
KYOWA HAKKO...
TOKYO: Kyowa Hakko Kirin Co., Ltd. (Chiyoda-ku, Tokyo Japan; President, Dr.
Yuzuru Matsuda) announced on January 15 (Tokyo Time) that it has decided to
continue the domestic development of its proprietary anti-Parkinson's disease
drug KW-6002 (generic name: Istradefylline) and move it forward with a Phase 3
clinical trial in Japan.
http://www.kyowa-kirin.co.jp/english/index.html
KYOWA HAKKO...
TOKYO: Kyowa Hakko Kirin Co., Ltd. (Chiyoda-ku, Tokyo Japan; President, Dr.
Yuzuru Matsuda) announced on January 15 (Tokyo Time) that it has decided to
continue the domestic development of its proprietary anti-Parkinson's disease
drug KW-6002 (generic name: Istradefylline) and move it forward with a Phase 3
clinical trial in Japan.
http://www.kyowa-kirin.co.jp/english/index.html
AsiaNet is a consortium of leading news agencies distributing unedited,
translated news releases for worldwide clients. Visit www.asianetnews.net for
full-text versions.